The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAcer Gdr Reg S Regulatory News (ACID)

Share Price Information for Acer Gdr Reg S (ACID)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.55
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 6.55
High: 0.00
Low: 0.00
Prev. Close: 6.55
ACID Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

To Modify the 2014 Utilization Plan of Cash Inject

6 Aug 2015 12:03

RNS Number : 3350V
Acer Incorporated
06 August 2015
 



Subject: Modification of the 2014 Utilization Plan of Funds Obtained Through the Sale of New Stocks

Date of events: 2015/08/06

Contents:

1. Date of the board of directors resolution for the change: 2015/08/06

2. Dates of effective registration of the original plan: 2014/10/21

3. Reason for the change:

Redemption repayment from the put option executed by the ECB holders in the original plan was implemented in Q2 2015. Due to the costs is lower than the redemption repayment from the put option, Acer had been continually purchasing back and cancelling the convertible bond from the market. The current amount of the convertible bond has been lessened from USD103, 800,000 to USD13, 400,000. Therefore, as of the expiration date of the options (July 27, 2015), only NT $459,815 thousand of the convertible bonds had been sold back by the bondholders, and NT $ 1,340,185 thousand of the increased capital remain unspent. For the effective use of the funds, it is proposed to change the purpose of the funds from "redemption repayment from the put option executed by the ECB holders" to "strengthening working capital", which will be able to effectively save interest of short-term bank financing expenditure and reduce financial burden.

4. Content of each and every successive past changed plan for raising of funds before and after change:

Before changing:

(1) Pay off bank loan: NTD 3.6 billion.

(2) Redemption repayment from the put option executed by the ECB holders: NTD3.516 billion.

After changing:

(1) Pay off bank loan: NTD 3.6 billion.

(2) Redemption repayment from the put option executed by the ECB holders: NTD 460 million

(3) Strengthening working capital: 1.34 billion

5. Anticipated timetable for execution:

(1) Pay off bank loan: Q2 and Q4 of 2015

(2) Redemption repayment from the put option executed by the ECB holders: Q3 2015

(3) Strengthening working capital: Q3 2015

6. Anticipated completion date:

(1) Pay off bank loan: Q2 and Q4 of 2015

(2) Redemption repayment from the put option executed by the ECB holders: Q3 2015

(3) Strengthening working capital: Q3 2015

7. Anticipated possible benefits:

(1) Pay off bank loan: based on assumed interest rate, it is expected that NTD 21 million could be saved in 2015, and NTD 72 million could be saved in the following years.

(2) Redemption repayment from the put option executed by the ECB holders: based on our current average interest rate which is 2%, it is expected that NTD 3.065 million could be saved in 2015, and NTD 9.196 million could be saved in the following years.

(3) Strengthening working capital: based on our current average interest rate which is 2%, it is expected that NTD 8.935 million could be saved in 2015, and NTD 26.804 million could be save d in the following years.

8. Difference with original anticipated benefits:

(1) Redemption repayment from the put option executed by the ECB holders: NTD 61.122 million could be saved by the new plan every year.

(2) Pay off bank loan: No difference

(3)Strengthening working capital: NTD 26.804 million could be save by the new plan every year.

9. Effect of the current change on shareholder equity:

As a response to changes in the financial planning, ACER reserves to maintain a stable banking facilities and working capital. The proposed modification will increase flexibility and scheduling the use of funds and improve the financial structure in the long run, there is no significant negative impact on shareholders' interests.

10. Abstract of the original lead underwriter's appraisal opinion:

The main reason for the Company to modify the plan is because the ECB holders did not sell back their bonds because of the economic fluctuation. In order to manage the capital more efficiently and lower the cost, the modifications of the original plan is necessary and reasonable.

11. Any other matters that need to be specified: N/A

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGGRMVZGKZM
Date   Source Headline
9th May 202410:59 amRNSTo announce the Company's information
18th Apr 202410:15 amRNSTo announce the Company's information
11th Apr 202410:23 amRNSTo announce the Company's information
10th Apr 202410:16 amRNSUn-Audited Monthly Sales Ended Mar. 31, 2024
2nd Apr 20247:00 amRNSTo Announce the Company's Infomation
14th Mar 202410:01 amRNSTo announce the Company's information
7th Mar 20249:45 amRNSUn-Audited Monthly Sales Ended Feb. 29, 2024
26th Feb 20249:38 amRNSTo announce the Company's information
19th Feb 20249:11 amRNSTo announce the Company's information
7th Feb 20248:03 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2024
17th Jan 202410:05 amRNSTo announce the Company's information
8th Jan 20249:24 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2023
27th Dec 20237:00 amRNSTo announce the Company's information
11th Dec 20239:44 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2023
9th Nov 20239:21 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2023
2nd Nov 20239:15 amRNSTo announce the Company's information
24th Oct 20232:34 pmRNSTo announce the Company's information
16th Oct 20237:24 amRNSTo announce the Company's information
11th Oct 202310:36 amRNSUn-Audited Monthly Sales Ended Sep. 30, 2023
26th Sep 202310:07 amRNSTo announce the Company's information
8th Sep 202310:20 amRNSTo announce the Company's sales and information
5th Sep 20237:10 amRNSTo announce the Company's information
23rd Aug 202310:17 amRNSTo announce the Company's information
9th Aug 202310:13 amRNSUn-Audited Monthly Sales Ended July 31, 2023
8th Aug 202312:16 pmRNSTo announce the Company's information
3rd Aug 20231:09 pmRNSTo announce the Company's information
10th Jul 20237:00 amRNSUn-Audited Monthly Sales Ended June 30, 2023
29th Jun 202310:54 amRNSTo announce the Company's information
8th Jun 202310:17 amRNSUn-Audited Monthly Sales Ended May 31, 2023
7th Jun 20237:00 amRNSTo announce the Company's information
9th May 202310:35 amRNSTo announce the Company's info and Monthly Revenue
4th May 202311:14 amRNSTo announce the Company's information
24th Apr 202310:32 amRNSTo announce the Company's information
11th Apr 202311:05 amRNSTo announce the Company's info and Monthly Revenue
11th Apr 20237:00 amRNSTo announce the Company's information
31st Mar 202310:13 amRNSTo announce the Company's information
16th Mar 202310:24 amRNSTo announce the Company's information
10th Mar 20239:06 amRNSUn-Audited Monthly Sales Ended Feb. 28, 2023
8th Mar 20232:23 pmRNSTo announce the Company's information
2nd Mar 20239:05 amRNSTo announce the Company's information
10th Feb 20239:05 amRNSUn-Audited Monthly Sales Ended Jan. 31, 2023
9th Jan 202310:07 amRNSUn-Audited Monthly Sales Ended Dec. 31, 2022
4th Jan 20239:56 amRNSTo announce the Company's information
16th Dec 20229:12 amRNSTo announce the Company's information
9th Dec 20229:06 amRNSUn-Audited Monthly Sales Ended Nov. 30, 2022
8th Dec 20229:20 amRNSTo announce the Company's information
5th Dec 20229:13 amRNSTo announce the Company's information
29th Nov 202211:14 amRNSTo announce the Company's information
9th Nov 20229:23 amRNSUn-Audited Monthly Sales Ended Oct. 31, 2022
8th Nov 20228:50 amRNSTo announce the Company's information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.